624 related articles for article (PubMed ID: 11713533)
1. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.
Nguyen VT; Kiss T; Michels AA; Bensaude O
Nature; 2001 Nov; 414(6861):322-5. PubMed ID: 11713533
[TBL] [Abstract][Full Text] [Related]
2. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.
Yang Z; Zhu Q; Luo K; Zhou Q
Nature; 2001 Nov; 414(6861):317-22. PubMed ID: 11713532
[TBL] [Abstract][Full Text] [Related]
3. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.
Michels AA; Nguyen VT; Fraldi A; Labas V; Edwards M; Bonnet F; Lania L; Bensaude O
Mol Cell Biol; 2003 Jul; 23(14):4859-69. PubMed ID: 12832472
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA.
Chen R; Yang Z; Zhou Q
J Biol Chem; 2004 Feb; 279(6):4153-60. PubMed ID: 14627702
[TBL] [Abstract][Full Text] [Related]
5. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.
Michels AA; Fraldi A; Li Q; Adamson TE; Bonnet F; Nguyen VT; Sedore SC; Price JP; Price DH; Lania L; Bensaude O
EMBO J; 2004 Jul; 23(13):2608-19. PubMed ID: 15201869
[TBL] [Abstract][Full Text] [Related]
6. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
7. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
8. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
10. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
[TBL] [Abstract][Full Text] [Related]
11. Identification of multiple cyclin subunits of human P-TEFb.
Peng J; Zhu Y; Milton JT; Price DH
Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
[TBL] [Abstract][Full Text] [Related]
12. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.
Cho S; Schroeder S; Kaehlcke K; Kwon HS; Pedal A; Herker E; Schnoelzer M; Ott M
EMBO J; 2009 May; 28(10):1407-17. PubMed ID: 19387490
[TBL] [Abstract][Full Text] [Related]
14. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.
Yik JH; Chen R; Nishimura R; Jennings JL; Link AJ; Zhou Q
Mol Cell; 2003 Oct; 12(4):971-82. PubMed ID: 14580347
[TBL] [Abstract][Full Text] [Related]
16. Functional inactivation of Cdk9 through oligomerization chain reaction.
Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
[TBL] [Abstract][Full Text] [Related]
18. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.
Egloff S; Van Herreweghe E; Kiss T
Mol Cell Biol; 2006 Jan; 26(2):630-42. PubMed ID: 16382153
[TBL] [Abstract][Full Text] [Related]
19. Cellular control of gene expression by T-type cyclin/CDK9 complexes.
Garriga J; Graña X
Gene; 2004 Aug; 337():15-23. PubMed ID: 15276198
[TBL] [Abstract][Full Text] [Related]
20. Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription.
Liu P; Xiang Y; Fujinaga K; Bartholomeeusen K; Nilson KA; Price DH; Peterlin BM
J Biol Chem; 2014 Apr; 289(14):9918-25. PubMed ID: 24515107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
